National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 66665 [2016-23314]
Download as PDF
<![CDATA[
66665
Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Responses
per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
New review participants .......................................................
Updating review participants information .............................
250
5,000
1
1
250
5,000
.166
.333
42
1,665
Total ..............................................................................
5,250
........................
5,250
........................
1,707
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–23306 Filed 9–27–16; 8:45 am]
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service 2016 Performance
Review Board (PRB)
The National Institutes of
Health (NIH) announces the persons
who will serve on the National
Institutes of Health’s Senior Executive
Service 2016 Performance Review
Board.
FOR FURTHER INFORMATION CONTACT: For
further information about the NIH
Performance Review Board, contact the
Office of Human Resources Division of
Senior and Scientific Executive
Management, National Institutes of
Health, Building 2, Room 5E18,
Bethesda, Maryland 20892, telephone
301–402–7999 (not a toll-free number).
SUPPLEMENTARY INFORMATION: This
action is being taken in accordance with
Title 5, U.S.C., Section 4314(c)(4),
which requires that members of
performance review boards be
appointed in a manner to ensure
consistency, stability, and objectivity in
performance appraisals and requires
that notice of the appointment of an
individual to serve as a member be
published in the Federal Register.
The following persons will serve on
the NIH Performance Review Board,
mstockstill on DSK3G9T082PROD with NOTICES
Jkt 238001
BILLING CODE 4140–01–P
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
National Institutes of Health
18:04 Sep 27, 2016
[FR Doc. 2016–23391 Filed 9–27–16; 8:45 am]
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Dated: September 22, 2016.
Francis S. Collins,
Director, National Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
SUMMARY:
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members:
Alfred Johnson, Chair, Joellen Austin,
Michelle Bulls, Michael Gottesman,
Michael Lauer, Andrea Norris, LaVerne
Stringfield, Lawrence Tabak, Timothy
Wheeles.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public as indicated
below in accordance with the provisions
set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review,
discussion, and evaluation of individual
grant applications conducted by the
NATIONAL INSTITUTE OF DIABETES
AND DIGESTIVE AND KIDNEY
DISEASES, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: October 20, 2016.
Open: 8:00 a.m. to 8:30 a.m.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Agenda: Introductions and Overview.
Place: National Institutes of Health,
Building 10, 9th Floor, Bunim Room 9S233,
10 Center Drive, Bethesda, MD 20892.
Closed: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 9th Floor, Bunim Room 9S233,
10 Center Drive, Bethesda, MD 20892.
Contact Person: Michael W. Krause, Ph.D.,
Scientific Director, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institute of Health, Building 5,
Room B104, Bethesda, MD 20892–1818, (301)
402–4633, mwkrause@helix.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 22, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–23314 Filed 9–27–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 81, Number 188 (Wednesday, September 28, 2016)]
[Notices]
[Page 66665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23314]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The meeting will be closed to
the public as indicated below in accordance with the provisions set
forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review,
discussion, and evaluation of individual grant applications conducted
by the NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
DISEASES, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: October 20, 2016.
Open: 8:00 a.m. to 8:30 a.m.
Agenda: Introductions and Overview.
Place: National Institutes of Health, Building 10, 9th Floor,
Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892.
Closed: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 9th Floor,
Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892.
Contact Person: Michael W. Krause, Ph.D., Scientific Director,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institute of Health, Building 5, Room B104, Bethesda, MD
20892-1818, (301) 402-4633, mwkrause@helix.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 22, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-23314 Filed 9-27-16; 8:45 am]
BILLING CODE 4140-01-P
